RU2376040C1 - Порошковый ингалятор - Google Patents
Порошковый ингалятор Download PDFInfo
- Publication number
- RU2376040C1 RU2376040C1 RU2008120838/14A RU2008120838A RU2376040C1 RU 2376040 C1 RU2376040 C1 RU 2376040C1 RU 2008120838/14 A RU2008120838/14 A RU 2008120838/14A RU 2008120838 A RU2008120838 A RU 2008120838A RU 2376040 C1 RU2376040 C1 RU 2376040C1
- Authority
- RU
- Russia
- Prior art keywords
- powder
- container
- holes
- movable plate
- sections
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 78
- 239000000443 aerosol Substances 0.000 claims abstract description 11
- 230000001681 protective effect Effects 0.000 claims abstract description 6
- 239000002270 dispersing agent Substances 0.000 claims description 9
- 210000004072 lung Anatomy 0.000 abstract description 15
- 239000003814 drug Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 14
- 229940079593 drug Drugs 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- 230000001105 regulatory effect Effects 0.000 description 4
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 3
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 3
- 229960004436 budesonide Drugs 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229960004017 salmeterol Drugs 0.000 description 3
- PJFHZKIDENOSJB-UHFFFAOYSA-N Budesonide/formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1.C1CC2=CC(=O)C=CC2(C)C2C1C1CC3OC(CCC)OC3(C(=O)CO)C1(C)CC2O PJFHZKIDENOSJB-UHFFFAOYSA-N 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 230000001133 acceleration Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 229940035073 symbicort Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241001132374 Asta Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010050346 Oropharyngeal candidiasis Diseases 0.000 description 1
- YYAZJTUGSQOFHG-IAVNQIGZSA-N [(6s,8s,10s,11s,13s,14s,16r,17r)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate;2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]eth Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)C1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O YYAZJTUGSQOFHG-IAVNQIGZSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940092705 beclomethasone Drugs 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960002714 fluticasone Drugs 0.000 description 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
- 229960000289 fluticasone propionate Drugs 0.000 description 1
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940071648 metered dose inhaler Drugs 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nozzles (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008120838/14A RU2376040C1 (ru) | 2008-05-27 | 2008-05-27 | Порошковый ингалятор |
| EA201001864A EA017662B1 (ru) | 2008-05-27 | 2009-05-27 | Порошковый ингалятор |
| PCT/RU2009/000265 WO2009145673A2 (fr) | 2008-05-27 | 2009-05-27 | Inhalateur de poudre |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2008120838/14A RU2376040C1 (ru) | 2008-05-27 | 2008-05-27 | Порошковый ингалятор |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2376040C1 true RU2376040C1 (ru) | 2009-12-20 |
Family
ID=41377824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008120838/14A RU2376040C1 (ru) | 2008-05-27 | 2008-05-27 | Порошковый ингалятор |
Country Status (3)
| Country | Link |
|---|---|
| EA (1) | EA017662B1 (fr) |
| RU (1) | RU2376040C1 (fr) |
| WO (1) | WO2009145673A2 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2833773C1 (ru) * | 2020-03-31 | 2025-01-28 | инвоКС Белджиум НВ | Ингаляционное устройство для образования аэрозоля из по меньшей мере двух жидких композиций, способ (варианты) лечения субъекта, страдающего от заболевания, с использованием ингаляционного устройства, применение комбинации первой и второй жидких композиций в способе лечения субъекта, страдающего от заболевания, с использованием ингаляционного устройства, первый резервуар, содержащий первую жидкую композицию, содержащую бета-агонист длительного действия, и второй резервуар, содержащий вторую жидкую композицию, выполненные с возможностью использования с ингаляционным устройством, применение ингаляционного устройства или первого резервуара, содержащего первую жидкую композицию, содержащую бета-агонист длительного действия, и способ доставки по меньшей мере двух жидких композиций субъекту |
| US12478748B2 (en) | 2020-03-31 | 2025-11-25 | Invox Belgium Nv | Aerosol delivery of at least two liquid compositions |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR095222A1 (es) * | 2013-04-03 | 2015-09-30 | Sanofi Sa | Elemento de medición para un dispositivo de inhalación y montaje para un dispositivo de inhalación que comprende un elemento de medición |
| SE538399C2 (sv) * | 2014-04-03 | 2016-06-14 | Iconovo Ab | Torrpulverinhalator |
| SE538400C2 (sv) * | 2014-04-03 | 2016-06-14 | Iconovo Ab | Torrpulverinhalator |
| SE539930C2 (sv) * | 2014-04-03 | 2018-01-23 | Iconovo Ab | Torrpulverinhalator |
| EP3294390B1 (fr) * | 2015-05-08 | 2022-10-05 | Iconovo AB | Inhalateur de poudre sèche |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0505321A3 (en) * | 1991-03-21 | 1993-01-27 | Ciba-Geigy Ag | Inhaler |
| RU2157251C2 (ru) * | 1994-09-16 | 2000-10-10 | Лаборатуар Глаксо Велльком С.А. | Устройство для ингаляции |
| RU2258539C1 (ru) * | 2004-03-23 | 2005-08-20 | Чучалин Александр Григорьевич | Порошковый ингалятор |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2080883C1 (ru) * | 1994-11-22 | 1997-06-10 | Александр Григорьевич Чучалин | Ингалятор |
| RU2163149C1 (ru) * | 1999-06-25 | 2001-02-20 | Чучалин Александр Григорьевич | Ингалятор для введения лекарственных средств в виде порошка |
-
2008
- 2008-05-27 RU RU2008120838/14A patent/RU2376040C1/ru not_active IP Right Cessation
-
2009
- 2009-05-27 WO PCT/RU2009/000265 patent/WO2009145673A2/fr not_active Ceased
- 2009-05-27 EA EA201001864A patent/EA017662B1/ru not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0505321A3 (en) * | 1991-03-21 | 1993-01-27 | Ciba-Geigy Ag | Inhaler |
| RU2157251C2 (ru) * | 1994-09-16 | 2000-10-10 | Лаборатуар Глаксо Велльком С.А. | Устройство для ингаляции |
| RU2258539C1 (ru) * | 2004-03-23 | 2005-08-20 | Чучалин Александр Григорьевич | Порошковый ингалятор |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2833773C1 (ru) * | 2020-03-31 | 2025-01-28 | инвоКС Белджиум НВ | Ингаляционное устройство для образования аэрозоля из по меньшей мере двух жидких композиций, способ (варианты) лечения субъекта, страдающего от заболевания, с использованием ингаляционного устройства, применение комбинации первой и второй жидких композиций в способе лечения субъекта, страдающего от заболевания, с использованием ингаляционного устройства, первый резервуар, содержащий первую жидкую композицию, содержащую бета-агонист длительного действия, и второй резервуар, содержащий вторую жидкую композицию, выполненные с возможностью использования с ингаляционным устройством, применение ингаляционного устройства или первого резервуара, содержащего первую жидкую композицию, содержащую бета-агонист длительного действия, и способ доставки по меньшей мере двух жидких композиций субъекту |
| US12478748B2 (en) | 2020-03-31 | 2025-11-25 | Invox Belgium Nv | Aerosol delivery of at least two liquid compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009145673A2 (fr) | 2009-12-03 |
| WO2009145673A3 (fr) | 2010-01-21 |
| EA017662B1 (ru) | 2013-02-28 |
| EA201001864A1 (ru) | 2011-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4405688B2 (ja) | 複合薬剤用の粉末吸入器 | |
| Atkins | Dry powder inhalers: an overview | |
| Lavorini et al. | Recent advances in capsule-based dry powder inhaler technology | |
| AU760749B2 (en) | Powder inhaler for combined medicament | |
| CN101384288B (zh) | 干粉吸入器设备 | |
| US20090250058A1 (en) | Inhalation System and Delivery Device for the Administration of a Drug in the Form of Dry Powder | |
| JP5404618B2 (ja) | ドライパウダー薬剤 | |
| EP1744800B1 (fr) | Inhalateur | |
| RU2376040C1 (ru) | Порошковый ингалятор | |
| JP2009537199A (ja) | 簡易吸入器 | |
| CN102596297B (zh) | 药物产品、干粉吸入器和多流碰撞器布置 | |
| Yang et al. | Drug delivery performance of the mometasone furoate dry powder inhaler | |
| CN110494181A (zh) | 用于输送干粉药物的装置和方法 | |
| CN116615201A (zh) | 丙酸氟替卡松和硫酸沙丁胺醇的可吸入制剂 | |
| EP3125977B1 (fr) | Inhalateur de poudre sèche | |
| SE527200C2 (sv) | Inhalatoranordning samt kombinerade doser av formaterol och fluticason | |
| Hejduk et al. | Technical challenges in obtaining an optimized powder/DPI combination for inhalation delivery of a bi-component generic drug | |
| RU2258539C1 (ru) | Порошковый ингалятор | |
| CN116077471A (zh) | 一种供吸入用的粉雾剂组合物及其制备方法和应用 | |
| WO2004110491A1 (fr) | Doses combinees | |
| WO2011110970A1 (fr) | Inhalateur de poudre sèche à dose unique | |
| Patel et al. | Devices for Dry Powder Drug Delivery to the Lung | |
| Asif et al. | Dry powder inhaler devices | |
| Hrindo et al. | Advanced drug delivery through an inhaler utilizing a venturi | |
| Kadu et al. | Journal of Advanced Drug Delivery (JADD) ISSN NO: 2348-3278 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110528 |